Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pancreatic Tubular Adenocarcinoma”

612 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 612 results

Testing effectiveness (Phase 2)Ended earlyNCT06478862
What this trial is testing

Promitil Treatment of Patients With Solid Tumors Associated With Deleterious Mutations Who Have Progressed After Therapy

Who this might be right for
Cancer of OvaryPancreatic Ductal Adenocarcinoma
Lipomedix Pharmaceuticals Inc. 19
Testing effectiveness (Phase 2)Looking for participantsNCT03608631
What this trial is testing

IExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation

Who this might be right for
KRAS NP_004976.2:p.G12DMetastatic Pancreatic AdenocarcinomaPancreatic Ductal Adenocarcinoma+1 more
M.D. Anderson Cancer Center 28
Early research (Phase 1)Ended earlyNCT05494866
What this trial is testing

A Trial of Cobicistat and Gemcitabine and Nab-Paclitaxel in Patients with Advanced Stage or Metastatic Pancreatic Ductal Adenocarcinoma

Who this might be right for
CYP3A InhibitorAdvanced Stage or Metastatic Pancreatic Ductal AdenocarcinomaPancreatic Cancer+2 more
German Cancer Research Center 6
Not applicableStudy completedNCT07224802
What this trial is testing

Forecasting Occult liveR Metastasis Using an Exosomal Signature for Intelligent Guided Hepatic Targeting

Who this might be right for
PDAC - Pancreatic Ductal Adenocarcinoma
City of Hope Medical Center 372
Early research (Phase 1)Study completedNCT03291938
What this trial is testing

IACS-010759 in Advanced Cancers

Who this might be right for
Advanced Malignant Solid NeoplasmAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8+22 more
M.D. Anderson Cancer Center 29
Testing effectiveness (Phase 2)Looking for participantsNCT05518903
What this trial is testing

Investigational Scan (68Ga-FAPI-46 PET/CT) for Imaging of Cancer-Associated Fibroblasts for Localized Pancreatic Ductal Adenocarcinoma

Who this might be right for
Localized Pancreatic AdenocarcinomaResectable Pancreatic Ductal AdenocarcinomaStage 0 Pancreatic Cancer AJCC v8+2 more
Mayo Clinic 130
Testing effectiveness (Phase 2)Study completedNCT05641896
What this trial is testing

Study of [18F]FAPI-74 PET in Patients With Gastrointestinal Cancers

Who this might be right for
Gastrointestinal CancersCholangiocarcinomaGastric Cancer+3 more
SOFIE 109
Early research (Phase 1)Looking for participantsNCT06131840
What this trial is testing

SGN-CEACAM5C in Adults With Advanced Solid Tumors

Who this might be right for
Colorectal NeoplasmsCarcinoma, Non-Small-Cell LungStomach Neoplasms+3 more
Seagen, a wholly owned subsidiary of Pfizer 914
Early research (Phase 1)WithdrawnNCT06017323
What this trial is testing

Proglumide With Gemcitabine and Nab-Paclitaxel in PatientsWith Metastatic Pancreatic Ductal Adenocarcinoma

Who this might be right for
Metastatic Pancreatic Cancer
Georgetown University
Large-scale testing (Phase 3)Looking for participantsNCT07217717
What this trial is testing

Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Pancreatic Ductal Adenocarcinoma (PDAC)

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)
SOFIE 200
Not applicableUnknownNCT04483726
What this trial is testing

Distal Pancreatectomy, Minimally Invasive or Open, for Malignancy (DIPLOMA)

Who this might be right for
Pancreatic Ductal Adenocarcinoma
University Hospital, Montpellier 9
Testing effectiveness (Phase 2)UnknownNCT03666832
What this trial is testing

Multi-center, Open-label, Phase 1b Clinical Trial to Evaluate the Safety, Tolerability, and Exploratory Efficacy of TEW-7197 in Combination With FOLFOX in Patients With Metastatic Pancreatic Ductal Adenocarcinoma Who Have Failed First-Line Gemcitabine and Nab-Paclitaxel

Who this might be right for
Metastatic Pancreatic Cancer
Joon Oh Park 36
Large-scale testing (Phase 3)Active Not RecruitingNCT06115499
What this trial is testing

The PLATINUM Trial: Optimizing Chemotherapy for the Second-Line Treatment of Metastatic BRCA1/2 or PALB2-Associated Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Acinar Cell CarcinomaPancreatic AdenocarcinomaPancreatic Adenosquamous Carcinoma+4 more
Alliance for Clinical Trials in Oncology 10
Testing effectiveness (Phase 2)Looking for participantsNCT07269626
What this trial is testing

PULSAR in Systemic Therapy for Pancreatic Cancer

Who this might be right for
Locally Advanced Pancreatic Ductal AdenocarcinomaBorderline Resectable Pancreatic Ductal AdenocarcinomaOligometastatic Pancreatic Ductal Adenocarcinoma
Samsung Medical Center 47
Testing effectiveness (Phase 2)Active Not RecruitingNCT06119217
What this trial is testing

Phase 2 Study of TTX-030 and Chemotherapy With or Without Budigalimab for 1L mPDAC Patients

Who this might be right for
Pancreatic Cancer
Trishula Therapeutics, Inc. 194
Testing effectiveness (Phase 2)Active Not RecruitingNCT04666740
What this trial is testing

Pembrolizumab and Olaparib for People With Metastatic Pancreatic Ductal Adenocarcinoma and Homologous Recombination Deficiency or Exceptional Treatment Response to Platinum-Based Therapy

Who this might be right for
Metastatic Pancreatic Ductal AdenocarcinomaHomologous Recombination Deficiency (HRD)
Memorial Sloan Kettering Cancer Center 63
Not applicableStudy completedNCT02787187
What this trial is testing

Lymphadenectomy for Pancreatic Head Cancer: Standard or Extended?

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Ruijin Hospital 230
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07475234
What this trial is testing

Rimegepant Combined With AG Chemotherapy As First-Line Treatment For Metastatic Pancreatic Ductal Adenocarcinoma

Who this might be right for
Metastatic Pancreatic Ductal Adenocarcinoma
Xiuchao Wang 30
Early research (Phase 1)Looking for participantsNCT07166601
What this trial is testing

M0324 as Monotherapy and in Combination With Pembrolizumab or Chemotherapy in Participants With Selected Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
EMD Serono Research & Development Institute, Inc. 77
Large-scale testing (Phase 3)Looking for participantsNCT06958328
What this trial is testing

Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer

Who this might be right for
Locally Advanced Unresectable Pancreatic Ductal AdenocarcinomaStage II Pancreatic Cancer AJCC v8Stage III Pancreatic Cancer AJCC v8+1 more
NRG Oncology 356
Load More Results